Avalo Therapeutics to join Russell 2000, 3000 indexes
Seeking Alpha ·
Avalo Therapeutics ( AVTX ) is set to join the small-cap Russell 2000 Index and the broad-market Russell 3000 Index. The addition is effective after the close of U.S. equity markets on June 26, 2026. Avalo Therapeutics: Sell-Off Could Continue If Overall Market Deteriorates Further Avalo Therapeutics: Abdakibart Delivers Breakout Phase 2 HS Data Avalo Therapeutics GAAP EPS of -$0.98 beats by $0.05 Avalo Therapeutics prices $375M public offering; shares jump Seeking Alpha’s Quant Rating on Avalo Therapeutics
DYAX Investor Sentiment
Bullish (Long) 44% · Bearish (Short) 56%
358 participants
Related News
- Omeros drops as transplant therapy faces EU hurdle
- Medicenna Therapeutics Corp. GAAP EPS of -C$0.22
- Coca-Cola's longstanding $20B tax case is off to a promising start in the courtroom
- FibroBiologics prices up to $9M private placement
- Samsung, SK Hynix Slide 9% Before $646 Billion Investment Update
- The Greenblatt Magic Formula: How H&R Block, Molina, and Peabody Stack Up for Retirement Investors